IL150742A0
(en )
2003-02-12
Pyridopyrimidinone derivatives for the treatment of neurodegenerative disease
IL145470A0
(en )
2002-06-30
Compositions for the treatment of immune diseases
IL196301A0
(en )
2009-09-22
Medicament for the treatment of hapatitis c
PL362711A1
(en )
2004-11-02
Morpholin-acetamide derivatives for the treatment of inflammatory diseases
GB0010669D0
(en )
2000-06-28
Compositions for treatment of disorders of the oesophagus
EP1463527A4
(en )
2005-05-11
USE OF GAMMAGLOBULIN FOR THE TREATMENT OF IMMUNE-MEDIATED DISEASES
HUP0104963A3
(en )
2002-11-28
Compositions for the treatment of skin diseases
IL153831A
(en )
2013-03-24
Pharmaceutical composition for therapy of neurodegenerative disease of the brain
AU2266801A
(en )
2001-07-03
Combination therapy for treating neurodegenerative disease
HK1038510B
(zh )
2005-05-20
使用神經營養因子興奮劑治療眼神經變性疾病
AU4215499A
(en )
2002-07-08
Treatment of neurodegenerative diseases
PL373490A1
(en )
2005-09-05
Use of beta-adrenoceptor agonists for the treatment of neurodegenerative diseases
GB9900222D0
(en )
1999-02-24
Therapeutic compounds
ZA200110539B
(en )
2003-03-24
Oxazinocarbazoles for the treatment of CNS diseases.
AU3004000A
(en )
2000-09-14
Methods for the treatment of apolipoprotein e related diseases
IL153439A0
(en )
2003-07-06
Medicines for the prevention and treatment of neurodegenerative diseases
SI1185293T1
(sl )
2006-02-28
Uporaba himer il6ril6 za zdravljenje nevrodegenerativnih bolezni
ZA991783B
(en )
1999-09-06
Therapeutic treatment for autoimmune diseases.
AU5854799A
(en )
2000-03-14
Novel treatment of neurodegenerative diseases
IL147188A0
(en )
2002-08-14
Il6ril6 chimera for the treatment of demyelinating diseases
AU2002344959A1
(en )
2003-11-17
Use of fasl for the treatment of neurodegenerative diseases
SI1200447T1
(sl )
2004-04-30
Oksazinokarbazoli za zdravljenje CNS bolezni
AU2001274446A1
(en )
2001-12-17
Vip-related peptides for the treatment of skin disorders
GB9926985D0
(en )
2000-01-12
Use of substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphonamides and-cyanamides for the treatment of diseases
PL350327A1
(en )
2002-12-02
Compositions for the treatment of skin diseases